Trial · NCT04435626
Adverse events2,811
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,811
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Finerenone (BAY94-8862) | 169 | 2,993 | 193 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo | 162 | 2,993 | 178 |
| other | Anaemia | Blood and lymphatic system disorders | Never Received Treatment | 0 | 15 | 0 |
| other | Cardiac failure | Cardiac disorders | Finerenone (BAY94-8862) | 116 | 2,993 | 143 |
| other | Cardiac failure | Cardiac disorders | Placebo | 168 | 2,993 | 218 |
| other | Cardiac failure | Cardiac disorders | Never Received Treatment | 0 | 15 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Finerenone (BAY94-8862) | 167 | 2,993 | 208 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 129 | 2,993 | 157 |
| other | Diarrhoea | Gastrointestinal disorders | Never Received Treatment | 0 | 15 | 0 |
| other | Urinary tract infection | Infections and infestations | Finerenone (BAY94-8862) | 150 | 2,993 | 184 |
| other | Urinary tract infection | Infections and infestations | Placebo | 149 | 2,993 | 194 |
| other | Urinary tract infection | Infections and infestations | Never Received Treatment | 0 | 15 | 0 |
| other | COVID-19 | Infections and infestations | Finerenone (BAY94-8862) | 292 | 2,993 | 301 |
| other | COVID-19 | Infections and infestations | Placebo | 297 | 2,993 | 318 |
| other | COVID-19 | Infections and infestations | Never Received Treatment | 0 | 15 | 0 |
| other | Glomerular filtration rate decreased | Investigations | Finerenone (BAY94-8862) | 156 | 2,993 | 219 |
| other | Glomerular filtration rate decreased | Investigations | Placebo | 107 | 2,993 | 144 |
| other | Glomerular filtration rate decreased | Investigations | Never Received Treatment | 0 | 15 | 0 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Finerenone (BAY94-8862) | 252 | 2,993 | 348 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Placebo | 107 | 2,993 | 139 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04435626/events